≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

L02BG Aromatase inhibitors

PheWeb

RX_L02BG

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L02BG

9080

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

6214

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

6214

diagram downward connector

Include endpoints None

6214

diagram downward connector
RX_L02BG

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 6214 6154 60
Unadjusted prevalence (%) 1.75 3.10 0.04
Mean age at first event (years) 63.21 63.39 44.22

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.12 7.80 [5.55, 10.95] 1.8e-32 573
15 years 0.02 3.50 [2.54, 4.83] 1.8e-14 237
5 years 0.01 9.41 [7.28, 12.18] 2.4e-65 302
1 year 0.00 4.48 [2.91, 6.91] 1.1e-11 28

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L02BG – L02BG Aromatase inhibitors
GWS hits:

Survival analyses between endpoints

↥

Plot

before L02BG Aromatase inhibitors
after L02BG Aromatase inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L02BG Aromatase inhibitors

↥